These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15982324)

  • 21. Nucleolar organizer regions in cirrhosis and hepatocellular carcinoma.
    Jain R; Malhotra V; Kumar N; Sarin SK
    Trop Gastroenterol; 1998; 19(3):100-1. PubMed ID: 9828706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
    Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
    J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones".
    Hunt JP; Varnholt H
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649
    [No Abstract]   [Full Text] [Related]  

  • 24. Expression of matrilin-2 in liver cirrhosis and hepatocellular carcinoma.
    Szabó E; Korpos E; Batmunkh E; Lotz G; Holczbauer A; Kovalszky I; Deák F; Kiss I; Schaff Z; Kiss A
    Pathol Oncol Res; 2008 Mar; 14(1):15-22. PubMed ID: 18386166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells.
    Fan W; Yang H; Liu T; Wang J; Li TW; Mavila N; Tang Y; Yang J; Peng H; Tu J; Annamalai A; Noureddin M; Krishnan A; Gores GJ; Martínez-Chantar ML; Mato JM; Lu SC
    Hepatology; 2017 Apr; 65(4):1249-1266. PubMed ID: 27981602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmenter of liver regeneration (ALR) exhibits a dual signaling impact on hepatic acute-phase response.
    Dayoub R; Buerger L; Ibrahim S; Melter M; Weiss TS
    Exp Mol Pathol; 2017 Jun; 102(3):428-433. PubMed ID: 28506765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
    Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C
    Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocarcinoma-intestine-pancreas/pancreatic associated protein (HIP/PAP) is expressed and secreted by proliferating ductules as well as by hepatocarcinoma and cholangiocarcinoma cells.
    Christa L; Simon MT; Brezault-Bonnet C; Bonte E; Carnot F; Zylberberg H; Franco D; Capron F; Roskams T; Bréchot C
    Am J Pathol; 1999 Nov; 155(5):1525-33. PubMed ID: 10550309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The differential expression of cytosolic carbonic anhydrase in human hepatocellular carcinoma.
    Kuo WH; Chiang WL; Yang SF; Yeh KT; Yeh CM; Hsieh YS; Chu SC
    Life Sci; 2003 Sep; 73(17):2211-23. PubMed ID: 12927591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis.
    Lu M; Nakamura RM; Dent ED; Zhang JY; Nielsen FC; Christiansen J; Chan EK; Tan EM
    Am J Pathol; 2001 Sep; 159(3):945-53. PubMed ID: 11549587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of Twist gene in human hepatocellular carcinoma and its clinicopathological significance].
    Li CH; Chen XP; Xu ZQ; Li GP; Guan J
    Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1353-6. PubMed ID: 17217825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma.
    Nishino R; Honda M; Yamashita T; Takatori H; Minato H; Zen Y; Sasaki M; Takamura H; Horimoto K; Ohta T; Nakanuma Y; Kaneko S
    J Hepatol; 2008 Aug; 49(2):207-16. PubMed ID: 18490072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics of hepatobiliary carcinogenesis.
    Nault JC; Zucman-Rossi J
    Semin Liver Dis; 2011 May; 31(2):173-87. PubMed ID: 21538283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progenitor gene DLK1 might be an independent prognostic factor of liver cancer.
    Jin ZH; Yang RJ; Dong B; Xing BC
    Expert Opin Biol Ther; 2008 Apr; 8(4):371-7. PubMed ID: 18352842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma.
    Lagana SM; Salomao M; Remotti HE; Knisely AS; Moreira RK
    Histopathology; 2015 Mar; 66(4):598-602. PubMed ID: 25378077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice.
    Gandhi CR; Chaillet JR; Nalesnik MA; Kumar S; Dangi A; Demetris AJ; Ferrell R; Wu T; Divanovic S; Stankeiwicz T; Shaffer B; Stolz DB; Harvey SA; Wang J; Starzl TE
    Gastroenterology; 2015 Feb; 148(2):379-391.e4. PubMed ID: 25448926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
    Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
    Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma.
    Fujimoto K; Kawaguchi T; Nakashima O; Ono J; Ohta S; Kawaguchi A; Tonan T; Ohshima K; Yano H; Hayabuchi N; Izuhara K; Sata M
    Oncol Rep; 2011 May; 25(5):1211-6. PubMed ID: 21347516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma.
    Zimmerman RL; Fogt F; Burke M; Murakata LA
    Oncol Rep; 2002; 9(4):689-92. PubMed ID: 12066193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.